Individualizing Narcolepsy: Using Clinical Evidence and Patient Factors to Improve Diagnosis and Optimize Therapeutic Management
Program DescriptionSleep experts Drs. Lynn Marie Trotti, Asim Roy, and Anne Marie Morse offer a comprehensive approach to narcolepsy treatment, embracing recent pharmacological advancements (e.g., pitolisant, solriamfetol, low sodium oxybate [LXB], once nightly sodium oxybate [ON-SXB]).
Category
Format
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
Cost $0.00
From the Ground Up: Evolving Strategies in the Identification and Team-based Management of Patients with Early-Stage Alzheimer’s Disease Neurobiology
Program DescriptionThe care of Alzheimer’s disease (AD) is involved, multifaceted, and variable depending on individual patient preferences.
Category
Format
Credits
Cost $0.00
Part 1: Suspicion, Identification, and Evaluation of Patients Who May Have Early Alzheimer’s Disease Neurobiology
Alzheimer’s disease (AD) is a complex condition to diagnose and treat due to its significant overlap in symptoms and even pathological elements with other conditions.
Category
Format
Credits
Cost $0.00
Part 2: Importance and Implications of Biomarkers in Diagnosis and Modern Treatment of Alzheimer’s Disease
Not only are cases of mild cognitive impairment (MCI) often not diagnosed, but more than 50% of these patients are misdiagnosed.
Category
Format
Credits
Cost $0.00
Part 3: Evolving Roles in Alzheimer’s Disease Management: Team-Based Care in the Modern Age of Disease-Modifying Therapy
Due to the growing complexity in the management of Alzheimer’s disease (AD), patient care falls under a wide umbrella of clinical team members across specialties, increasing the complexity of disease management.
Category
Format
Credits
Cost $0.00
Battle of the Biomarkers: Assessing Key Factors in Prognosis, Monitoring, and Therapeutic Decision-Making for Disease Worsening in Multiple Sclerosis
OverviewOver the past several years, the image of MS has been changing from distinct categories of disease to a complicated spectrum of interwoven pathologies. As this knowledge evolves, so do approaches to prognosticating, monitoring, and responding to disease.
Category
Format
Credits
Cost $0.00
A Deeper Look at Neuromyelitis Optica Spectrum Disorder: A Glimpse Onto the Clinic Floor with Specialists
OverviewThough neuromyelitis optica spectrum disorder (NMOSD) has had a specific lab marker (AQP4 antibody) for many years, its relapsing nature and overlapping syndromes still causes it to be confused with multiple conditions such as multiple sclerosis (MS), leading to inappropriate and
Category
Format
Credits
Cost $0.00
Stronger Together: Leveraging Evidence-Based Patient Collaboration and Treatment Strategies to Streamline Success in Multiple Sclerosis
Program DescriptionWith the variety of possible risk factors, presentations, impacts, and preferences among individual patients with multiple sclerosis (MS), it has been well-established that every case of MS is unique.
Category
Format
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
Cost $0.00
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management
Due to the unique educational design of this course, the content must be viewed and completed on the ReachMD plat
Category
Format
Credits
Cost $0.00
A Journey Through Migraine: Using Modern Evidence, Expert Insight, and Practice Simulation to Navigate Daily Challenges
Due to the unique educational design of this course, the content must be viewed and completed on the myCME platform.Program Description1 in 6 adults in the US
Category
Format
Credits
Cost $0.00